<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ballard CJ</submitter><funding>Fondo Europeo de Desarrollo Regional</funding><funding>Complex Carbohydrate Research Center, University of Georgia</funding><funding>Ministry of Education and Science</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><funding>NIGMS NIH HHS</funding><funding>Danish National Research Foundation</funding><funding>Gobierno de Aragón</funding><pagination>817-836</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10629720</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>33(10)</volume><pubmed_abstract>A large family of polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts) initiate mucin type O-glycosylation transferring α-GalNAc from a UDP-GalNAc donor to the hydroxyl groups of Ser and Thr residues of peptides and proteins, thereby defining sites of O-glycosylation. Mutations and differential expression of several GalNAc-Ts are associated with many disease states including cancers. The mechanisms by which these isozymes choose their targets and their roles in disease are not fully understood. We previously showed that the GalNAc-Ts possess common and unique specificities for acceptor type, peptide sequence and prior neighboring, and/or remote substrate GalNAc glycosylation. In the present study, the role of flanking charged residues was investigated using a library of charged pepti</pubmed_abstract><journal>Glycobiology</journal><pubmed_title>Polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) isozyme surface charge governs charge substrate preferences to modulate mucin type O-glycosylation.</pubmed_title><pmcid>PMC10629720</pmcid><funding_grant_id>P01-GM107012</funding_grant_id><funding_grant_id>R01 CA078834</funding_grant_id><funding_grant_id>E34_R17</funding_grant_id><funding_grant_id>LMP58_18</funding_grant_id><funding_grant_id>R01 GM113534</funding_grant_id><funding_grant_id>P41-GM103390</funding_grant_id><funding_grant_id>PID2019-105451GB-I00</funding_grant_id><funding_grant_id>2014–2020</funding_grant_id><funding_grant_id>R01-GM113534</funding_grant_id><funding_grant_id>P01 GM107012</funding_grant_id><funding_grant_id>P41 GM103390</funding_grant_id><funding_grant_id>DNRF107</funding_grant_id><pubmed_authors>Hurtado-Guerrero R</pubmed_authors><pubmed_authors>Ballard CJ</pubmed_authors><pubmed_authors>Paul Daniel EJ</pubmed_authors><pubmed_authors>Gerken TA</pubmed_authors><pubmed_authors>Paserba MR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) isozyme surface charge governs charge substrate preferences to modulate mucin type O-glycosylation.</name><description>A large family of polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts) initiate mucin type O-glycosylation transferring α-GalNAc from a UDP-GalNAc donor to the hydroxyl groups of Ser and Thr residues of peptides and proteins, thereby defining sites of O-glycosylation. Mutations and differential expression of several GalNAc-Ts are associated with many disease states including cancers. The mechanisms by which these isozymes choose their targets and their roles in disease are not fully understood. We previously showed that the GalNAc-Ts possess common and unique specificities for acceptor type, peptide sequence and prior neighboring, and/or remote substrate GalNAc glycosylation. In the present study, the role of flanking charged residues was investigated using a library of charged pepti</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Oct</publication><modification>2026-04-19T03:24:51.712Z</modification><creation>2025-06-01T12:02:46.59Z</creation></dates><accession>S-EPMC10629720</accession><cross_references><pubmed>37555669</pubmed><doi>10.1093/glycob/cwad066</doi></cross_references></HashMap>